ARS Pharmaceuticals Inc
SPRY10.310USD
+0.030+0.29%
Fechamento 10/03, 16:00（ET）Cotações atrasadas em 15 min
1.02BValor de mercado
PerdaP/L TTM
Mais detalhes de ARS Pharmaceuticals Inc Empresa
ARS Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing neffy, for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, administered and nasal spray. Type I allergic reactions are potentially life-threatening hypersensitivity reactions that can occur within minutes of exposure to an allergen and need to be treated immediately to relieve symptoms and prevent further progression.
Informações de ARS Pharmaceuticals Inc
Código da empresaSPRY
Nome da EmpresaARS Pharmaceuticals Inc
Data de listagemDec 04, 2020
CEOMr. Richard E. Lowenthal
Número de funcionários155
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 04
Endereço11682 El Camino Real, Suite 120
CidadeSAN DIEGO
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal92130
Telefone18587719307
Sitehttps://ars-pharma.com/
Código da empresaSPRY
Data de listagemDec 04, 2020
CEOMr. Richard E. Lowenthal
Executivos da empresa ARS Pharmaceuticals Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Richard E. Lowenthal
Mr. Richard E. Lowenthal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.83M
-14.34%
Dr. Sarina Tanimoto, M.D.
Dr. Sarina Tanimoto, M.D.
Chief Medical Officer
Chief Medical Officer
4.57M
-10.85%
Mr. Justin Chakma
Mr. Justin Chakma
Chief Business Officer
Chief Business Officer
136.38K
--
Mr. Alexander A. Fitzpatrick, Esq., J.D.
Mr. Alexander A. Fitzpatrick, Esq., J.D.
Secretary and Chief Legal Officer
Secretary and Chief Legal Officer
86.26K
-3.33%
Mr. Michael Kelly
Mr. Michael Kelly
Independent Director
Independent Director
83.22K
--
Mr. Brian T. Dorsey
Mr. Brian T. Dorsey
Chief Operating Officer
Chief Operating Officer
7.65K
--
Dr. Laura K. Shawver, Ph.D.
Dr. Laura K. Shawver, Ph.D.
Director
Director
--
--
Dr. Rajeev Dadoo, Ph.D.
Dr. Rajeev Dadoo, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen D. (Kathy) Scott
Ms. Kathleen D. (Kathy) Scott
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Pratik Shah, Ph.D.
Dr. Pratik Shah, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Richard E. Lowenthal
Mr. Richard E. Lowenthal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.83M
-14.34%
Dr. Sarina Tanimoto, M.D.
Dr. Sarina Tanimoto, M.D.
Chief Medical Officer
Chief Medical Officer
4.57M
-10.85%
Mr. Justin Chakma
Mr. Justin Chakma
Chief Business Officer
Chief Business Officer
136.38K
--
Mr. Alexander A. Fitzpatrick, Esq., J.D.
Mr. Alexander A. Fitzpatrick, Esq., J.D.
Secretary and Chief Legal Officer
Secretary and Chief Legal Officer
86.26K
-3.33%
Mr. Michael Kelly
Mr. Michael Kelly
Independent Director
Independent Director
83.22K
--
Mr. Brian T. Dorsey
Mr. Brian T. Dorsey
Chief Operating Officer
Chief Operating Officer
7.65K
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qua, 3 de set
Atualizado em: qua, 3 de set
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
RA Capital Management, LP
11.07%
OrbiMed Advisors, LLC
8.39%
Deerfield Management Company, L.P.
7.70%
Lowenthal (Richard E)
6.91%
Pratik Shah Living Trust
4.88%
Outro
61.05%
Investidores
Investidores
Proporção
RA Capital Management, LP
11.07%
OrbiMed Advisors, LLC
8.39%
Deerfield Management Company, L.P.
7.70%
Lowenthal (Richard E)
6.91%
Pratik Shah Living Trust
4.88%
Outro
61.05%
Tipos de investidores
Investidores
Proporção
Hedge Fund
21.29%
Investment Advisor
19.12%
Investment Advisor/Hedge Fund
18.57%
Venture Capital
15.15%
Individual Investor
12.08%
Private Equity
8.39%
Corporation
4.88%
Research Firm
2.70%
Sovereign Wealth Fund
0.44%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
372
85.58M
86.60%
-4.54M
2025Q2
367
96.00M
97.76%
-11.66M
2025Q1
380
100.63M
102.48%
-12.75M
2024Q4
345
96.62M
99.42%
-14.07M
2024Q3
320
88.19M
90.90%
-18.52M
2024Q2
291
87.17M
89.94%
-20.35M
2024Q1
289
89.45M
92.60%
-16.44M
2023Q4
280
92.18M
96.08%
-6.49M
2023Q3
283
95.82M
104.35%
+1.21M
2023Q2
278
88.26M
96.94%
-730.20K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
RA Capital Management, LP
10.94M
11.07%
+80.00K
+0.74%
Sep 29, 2025
OrbiMed Advisors, LLC
8.29M
8.39%
--
--
Jun 30, 2025
Deerfield Management Company, L.P.
7.61M
7.7%
-2.11M
-21.74%
Jul 30, 2025
Lowenthal (Richard E)
6.83M
6.91%
-1.14M
-14.34%
Mar 31, 2025
Pratik Shah Living Trust
4.82M
4.88%
--
--
Mar 31, 2025
Tanimoto (Sarina)
4.57M
4.63%
-556.66K
-10.85%
Mar 31, 2025
SR One Capital Management, LP
4.01M
4.06%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.93M
3.98%
+47.01K
+1.21%
Jun 30, 2025
AllianceBernstein L.P.
3.83M
3.87%
-97.01K
-2.47%
Jun 30, 2025
The Vanguard Group, Inc.
3.25M
3.29%
-228.66K
-6.57%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: qui, 2 de out
Atualizado em: qui, 2 de out
Nome
Proporção
Invesco Dorsey Wright Healthcare Momentum ETF
0.86%
ALPS Medical Breakthroughs ETF
0.67%
First Trust Small Cap Growth AlphaDEX Fund
0.39%
SPDR S&P Biotech ETF
0.23%
First Trust Small Cap Core Alphadex Fund
0.19%
Direxion Daily S&P Biotech Bull 3X Shares
0.14%
Invesco Nasdaq Biotechnology ETF
0.12%
ProShares Ultra Nasdaq Biotechnology
0.12%
Principal U.S. Small-Cap ETF
0.09%
First Trust Multicap Growth Alphadex Fund
0.08%
Ver Mais
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção0.86%
ALPS Medical Breakthroughs ETF
Proporção0.67%
First Trust Small Cap Growth AlphaDEX Fund
Proporção0.39%
SPDR S&P Biotech ETF
Proporção0.23%
First Trust Small Cap Core Alphadex Fund
Proporção0.19%
Direxion Daily S&P Biotech Bull 3X Shares
Proporção0.14%
Invesco Nasdaq Biotechnology ETF
Proporção0.12%
ProShares Ultra Nasdaq Biotechnology
Proporção0.12%
Principal U.S. Small-Cap ETF
Proporção0.09%
First Trust Multicap Growth Alphadex Fund
Proporção0.08%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
